CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net earnings	$ 484,228	$ 404,978	$ 354,509
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	124,817	107,667	116,172
(Gain)/loss on sale/disposal of long-lived assets	362	(10)	(2,883)
Deferred income taxes	14,995	(11,822)	2,908
Share-based compensation	21,520	18,888	16,803
Non-cash restructuring charges	468	4,274	0
Changes in operating assets and liabilities, net of businesses acquired and disposed of:
Receivables, net	(82,850)	(88,808)	(2,394)
Inventories, net	(63,482)	(34,500)	(21,568)
Accounts payable and accrued expenses	73,929	16,024	(15,779)
Deferred revenue	97,683	144,269	47,914
Pension and postretirement liabilities, net	(27,526)	(18,880)	(18,307)
Other current and long-term assets and liabilities	(742)	2,195	(29,286)
Net cash provided by operating activities	643,402	544,275	448,089
Cash flows from investing activities:
Proceeds from sale/disposal of long-lived assets	1,268	3,206	9,147
Additions to property, plant, and equipment	(89,692)	(60,974)	(44,666)
Proceeds from sale of equity securities	7,919	0	0
Acquisition of businesses, net of cash acquired	0	(225,541)	0
Additional consideration paid on prior year acquisitions	(9,619)	0	0
Net cash used for investing activities	(90,124)	(283,309)	(35,519)
Cash flows from financing activities:
Borrowings under revolving credit facilities	475,100	21,309	638,116
Payment of revolving credit facilities	(475,100)	(21,309)	(638,116)
Principal payments on debt	(90,000)	0	(202,500)
Repurchases of company stock	(464,950)	(250,000)	(50,141)
Proceeds from share-based compensation plans	12,538	11,345	10,584
Dividends paid	(34,727)	(31,656)	(30,249)
Other	(1,159)	(1,182)	(1,097)
Net cash used for financing activities	(578,298)	(271,493)	(273,403)
Effect of exchange-rate changes on cash	11,323	(11,298)	10,726
Net increase (decrease) in cash and cash equivalents	(13,697)	(21,825)	149,893
Cash and cash equivalents at beginning of period	385,042	406,867	256,974
Cash and cash equivalents at end of period	$ 371,345	$ 385,042	$ 406,867